Clinical trial
SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate…
NCT00006002 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00006002 |
|---|---|
| Title | SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | A Phase II Trial of SU5416 (NSC# 686819) in Patients With Hormone Refractory Prostate Cancer |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | dexamethasone, semaxanib |
| Enrollment | 36 |
| Start date | Jun 1, 2000 |
| Primary completion | Sep 1, 2002 |
| Completion | Jan 1, 2006 |
| First posted | Aug 29, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: